<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2024-2S-57-64</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2317</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis</article-title><trans-title-group xml:lang="ru"><trans-title>Уровень цитокинов у пациентов с рассеянным склерозом и хроническим нейроборрелиозом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баранова</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Baranova</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Сергеевна Баранова</p><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>Natalya Sergeevna Baranova</p><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><email xlink:type="simple">baranova_ns@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Овсянникова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ovsyannikova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Остапенко</surname><given-names>Я. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ostapenko</surname><given-names>Ya. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спирин</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Spirin</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баранов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Baranov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Грись</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Gris</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артюхов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Artyukhov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>1, Ostrovityanovа St., Moscow 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Манякина</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Manyakina</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>150000, Ярославль, ул. Революционная, 5</p></bio><bio xml:lang="en"><p>5, Revolutsionnaya St., Yaroslavl 150000</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>08</month><year>2024</year></pub-date><volume>16</volume><issue>0</issue><issue-title>(Suppl. 2)</issue-title><fpage>57</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Baranova N.S., Ovsyannikova L.A., Ostapenko Y.S., Spirin N.N., Baranov A.A., Gris M.S., Artyukhov A.S., Manyakina Y.V., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Баранова Н.С., Овсянникова Л.А., Остапенко Я.С., Спирин Н.Н., Баранов А.А., Грись М.С., Артюхов А.С., Манякина Ю.В.</copyright-holder><copyright-holder xml:lang="en">Baranova N.S., Ovsyannikova L.A., Ostapenko Y.S., Spirin N.N., Baranov A.A., Gris M.S., Artyukhov A.S., Manyakina Y.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2317">https://nnp.ima-press.net/nnp/article/view/2317</self-uri><abstract><p>An imbalance in the production of proand anti-inflammatory cytokines plays an important role in the pathogenesis of multiple sclerosis (MS) and chronic neuroborreliosis (CNB).</p><sec><title>Objective</title><p>Objective: to perform a comparative analysis of cytokine production in patients with MS and CNB in order to evaluate the differential diagnostic potential of a multiplex assay of the concentration of the most important cytokines.</p></sec><sec><title>Material and methods</title><p>Material and methods. Fifty-seven patients participated in the study. The group of patients with relapsing-remitting MS consisted of 36 individuals (12 men and 24 women), median age – 38.5 [28.0; 48.50] years, MS duration – 9.5 [3.5; 12.5] years. Clinical reactivation of persistent herpesvirus infection (PHVI) was present in 18 (50%) patients. The group of patients with CNB comprised 21 patients (4 men and 17 women) aged 59.0 [52.0; 67.0] years with a disease duration of 2.5 [1.0; 4.0] years. 18 healthy donors were analyzed as controls. The concentrations of 15 cytokines in blood serum: interleukin 1β (IL1β), IL4, IL6, IL10, IL17A, IL17F, IL21, IL22, IL23, IL25, IL31, IL33, interferon γ (IFNγ), tumor necrosis factor α (TNFα), soluble CD40 ligand (sCD40L) were determined by xMAP multiplex technology using reagents produced by Bio-Rad (USA).</p></sec><sec><title>Results</title><p>Results. A significant increase in the levels of IL10 and IL33 (p&lt;0.001) and a decrease in the levels of IL1β, IL17F, IL22, IL25 and TNFα were found in patients with MS compared to controls. In patients with CNB, the levels of IL6, IL22, TNFα and sCD40L were significantly lower than in donors (p&lt;0.05 and p&lt;0.001), and the levels of IL10, IL17A, IL23, IL31, IL33 did not differ from the control. The concentrations of IL1β, IL4, IL17F, IL21, IL25 and IFNγ in patients with CNB were below the detection limit for these analytes. In patients with MS, the concentrations of IL6, IL10, IL17A, IL31, IL33, TNFα and sCD40L were significantly higher than in CNB. In contrast, IL23 levels were higher in CNB than in MS (p&lt;0.01). High levels (M+3σ in the control group) of IL33 occurred significantly more frequently in MS than in CNB (52.8 and 0.0% of cases; p&lt;0.001). In MS, overproduction of IL17A (2.8%), IL17F (5.6%), IL21 (5.6%) and IL31 (13.8%) was found. In CNB, an isolated increase in IL31 concentration was found in 4 (19.4%) patients. In MS with and without PHVI reactivation, the concentrations of IL6, IL10, IL17A, IL31, IL33, TNFα and sCD40L were significantly higher than in CNB; the greatest differences to CNB were found in the group of MS patients with PHVI reactivation. In CNB, IL23 levels were significantly higher than in MS with or without manifestations of PHVI.</p></sec><sec><title>Conclusion</title><p>Conclusion. There are significant differences in the production of proand anti-inflammatory cytokines in patients with MS and CNB, which are due to different etiological factors and characteristics of the immune response. In MS, against the background of an increase in IL10 levels, a concomitant increase in blood serum levels of IL6, IL17A, IL31, IL33, TNFα and sCD40L is characteristic, whereas in CND, with a low concentration of IL10 and most of the above proinflammatory cytokines, high levels of IL23 and an isolated increase in IL31 levels are seen. The differences identified can have practical application in the differential diagnosis between these diseases.</p></sec></abstract><trans-abstract xml:lang="ru"><p>В патогенезе рассеянного склероза (РС) и хронического нейроборрелиоза (ХНБ) важную роль играет дисбаланс выработки прои противовоспалительных цитокинов.</p><p>Цель исследования – провести сравнительный анализ продукции цитокинов у больных РС и ХНБ для оценки дифференциально-диагностического потенциала мультиплексной оценки уровня основных цитокинов.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование было включено 57 пациентов. Группу больных РС с ремиттирующим течением составили 36 человек (12 мужчин и 24 женщины), медиана возраста – 38,5 [28,0; 48,50] года, длительность РС – 9,5 [3,5; 12,5] года. У 18 (50,0%) больных имела место клиническая реактивация персистирующей герпес-вирусной инфекции (ПГВИ). В группу больных ХНБ вошел 21 больной (4 мужчины и 17 женщин) в возрасте 59,0 [52,0; 67,0] года с длительностью заболевания 2,5 [1,0; 4,0] года. В качестве контроля обследовано 18 здоровых доноров. Концентрацию 15 цитокинов в сыворотке крови: интерлейкина 1β (ИЛ1β), ИЛ4, ИЛ6, ИЛ10, ИЛ17А, ИЛ17F, ИЛ21, ИЛ22, ИЛ23, ИЛ25, ИЛ31, ИЛ33, интерферона γ (ИФНγ), фактора некроза опухоли α (ФНОα), растворимого CD40-лиганда (sCD40L) – определяли с помощью мультиплексной технологии хMАР с использованием реагентов производства Bio-Rad (США).</p></sec><sec><title>Результаты</title><p>Результаты. У больных РС, в сравнении с контролем, выявлено значимое повышение уровней ИЛ10 и ИЛ33 (р&lt;0,001) и снижение значений ИЛ1β, ИЛ17F, ИЛ22, ИЛ25 и ФНОα. У пациентов с ХНБ значения ИЛ6, ИЛ22, ФНОα и sCD40L были значимо ниже, чем у доноров (р&lt;0,05 и p&lt;0,001), а уровни ИЛ10, ИЛ17A, ИЛ23, ИЛ31, ИЛ33 не отличались от контроля. Концентрация ИЛ1β, ИЛ4, ИЛ17F, ИЛ21, ИЛ25 и ИФНγ у больных ХНБ была ниже предела чувствительности измерения этих аналитов. У пациентов с РС концентрации ИЛ6, ИЛ10, ИЛ17А, ИЛ31, ИЛ33, ФНОα и sCD40L были значимо выше, чем при ХНБ. Напротив, при ХНБ уровень ИЛ23 был выше, чем при РС (p&lt;0,01). При РС значимо чаще, чем при ХНБ, встречались высокие значения (M+3σ в группе контроля) ИЛ33 (52,8 и 0,0% случаев; p&lt;0,001). При РС регистрировалась гиперпродукция ИЛ17А (2,8%), ИЛ17F (5,6%), ИЛ21 (5,6%) и ИЛ31 (13,8%). При ХНБ обнаружено изолированное повышение концентрации ИЛ31 у 4 (19,4%) пациентов. При РС с реактивацией ПГВИ и без таковой концентрации ИЛ6, ИЛ10, ИЛ17А, ИЛ31, ИЛ33, ФНОα и sCD40L были значимо выше, чем при ХНБ; наибольшие различия с ХНБ получены для группы больных РС с реактивацией ПГВИ. При ХНБ уровень ИЛ23 был значимо выше, чем при РС с наличием или отсутствием проявлений ПГВИ.</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов с РС и ХНБ отмечаются существенные различия в продукции прои противовоспалительных цитокинов, обусловленные разными этиологическими факторами и особенностями иммунного ответа. Для РС, на фоне повышения концентрации ИЛ10, характерно одновременное увеличение в сыворотке крови уровней ИЛ6, ИЛ17А, ИЛ31, ИЛ33, ФНОα и sCD40L, а при ХНБ, при низкой концентрации ИЛ10 и большинства указанных выше провоспалительных цитокинов, – высокие значения ИЛ23 и изолированное повышение уровня ИЛ31. Выявленные различия могут найти практическое применение при проведении дифференциальной диагностики между этими заболеваниями.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>рассеянный склероз</kwd><kwd>хронический нейроборрелиоз</kwd><kwd>цитокины</kwd><kwd>герпес</kwd></kwd-group><kwd-group xml:lang="en"><kwd>multiple sclerosis</kwd><kwd>chronic neuroborreliosis</kwd><kwd>cytokines</kwd><kwd>herpes</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке ФГБУ «Фонд содействия развитию малых форм предприятий в научнотехнической сфере» (Фонд содействия инновациям) в рамках программы «УМНИК: Участник молодежного научно-инновационного конкурса» (договоры № 3560ГУ1/2014 от 23.09.2014, № 8815ГУ2/2015 от 17.12.2015). Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The work was carried out with the financial support of the Federal State Budgetary Institution “Fund for Support of Small Innovative Enterprises in the Scientific and Technical Sphere” (Innovation Support Fund) within the framework of the program “UMNIK: Participants of the Scientific and Innovative Youth Competition” (contract No. 3560ГУ1/2014 dated 23.09.2014, № 8815ГУ2/2015 dated 17.12.2015). The investigation has not been sponsored</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко АН, Гусев ЕИ. Современные алгоритмы диагностики и лечения рассеянного склероза, основанные на индивидуальной оценке состояния пациента. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2017;117(2 5. Баранова НС, Спирин НН, Овсяннико and Psychiatry. 2014;114(2-2):29-34 (In 2):92-106. doi: 10.17116/jnevro20171172292-106</mixed-citation><mixed-citation xml:lang="en">Boyko AN, Gusev EI. Current algorithms of diagnosis and treatment of multiple sclerosis based on the individual assessment of the patient. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(2-2):92 106. doi: 10.17116/jnevro20171172292-106 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Спирин НН, Баранова НС, Фадеева ОА и др. Дифференциальная диагностика поздних форм нейроборрелиоза с поражением центральной нервной системы. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2012;112(9-2):34-9.</mixed-citation><mixed-citation xml:lang="en">Spirin NN, Baranova NS, Fadeeva OA, et al. Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(9-2):34-9 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Koedel U, Pfister HW. Lyme neuroborreliosis. Curr Opin Infect Dis. 2017</mixed-citation><mixed-citation xml:lang="en">Koedel U, Pfister HW. Lyme neuroborreliosis. Curr Opin Infect Dis. 2017</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Halperin JJ. A Neurologist's View of Lyme Disease and Other Tick-Borne Infections. Semin Neurol. 2019 Aug;39(4):440-7. doi: 10.1055/s-0039-1692143. Epub 2019 Sep 18.</mixed-citation><mixed-citation xml:lang="en">Halperin JJ. A Neurologist's View of Lyme Disease and Other Tick-Borne Infections. Semin Neurol. 2019 Aug;39(4):440-7. doi: 10.1055/s-0039-1692143. Epub 2019 Sep 18.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Баранова НС, Спирин НН, Овсянникова ЛА и др. Поражение нервной системы при Лайм-боррелиозе. Терапия. 2021;(5):51-9. doi: 10.18565/therapy.2021.5.51-59</mixed-citation><mixed-citation xml:lang="en">Baranova NS, Spirin NN, Ovsyannikova LA, et al. Nervous system damage in Lyme borreliosis. Terapiya = Therapy. 2021;(5):51-9. doi: 10.18565/therapy.2021.5.51-59 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чуприна ЛА, Пилипенко ЕБ, Вербенко ПС. Аспекты дифференциальной диагностики Лайм-боррелиозного энцефалита и рассеянного склероза. Описание клинического случая. Таврический медико-биологический вестник. 2022;25(4):55-61. doi: 10.29039/2070-8092-2022-25-4-55-61</mixed-citation><mixed-citation xml:lang="en">Chuprina LA, Pilipenko EB, Verbenko PS. Aspects of differential diagnosis of Lyme-borreliosis encephalitis and multiple sclerosis. Description of a clinical case. Tavricheskiy medico-biologicheskiy vestnik. 2022;25(4):55-61. doi: 10.29039/2070-8092-2022-25-4-55-61 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Попова ЕВ, Бойко АН, Хачанова НВ, Шаранова СН. Вирус Эпштейна–Барр в патогенезе рассеянного склероза (обзор). Журнал неврологии и психиатрии</mixed-citation><mixed-citation xml:lang="en">Popova EV, Boyko AN, Khachanova NV, Sharanova SN. Epstein-Barr virus in the pathogenesis of multiple sclerosis (a review). Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(2-2):29-34 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Attfield KE, Jensen LT, Kaufmann M, et al. The immunology of multiple sclerosis. Nat Rev Immunol. 2022 Dec;22(12):734-50. doi: 10.1038/s41577-022-00718-z. Epub 2022 May 4.</mixed-citation><mixed-citation xml:lang="en">Attfield KE, Jensen LT, Kaufmann M, et al. The immunology of multiple sclerosis. Nat Rev Immunol. 2022 Dec;22(12):734-50. doi: 10.1038/s41577-022-00718-z. Epub 2022 May 4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.</mixed-citation><mixed-citation xml:lang="en">Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Engdahl E, Gustafsson R, Huang J, et al. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis. Front Immunol. 2019 Nov 26;10:2715. doi: 10.3389/fimmu.2019.02715</mixed-citation><mixed-citation xml:lang="en">Engdahl E, Gustafsson R, Huang J, et al. Increased Serological Response Against Human Herpesvirus 6A Is Associated With Risk for Multiple Sclerosis. Front Immunol. 2019 Nov 26;10:2715. doi: 10.3389/fimmu.2019.02715</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pietropaolo V, Fioriti D, Mischitelli M, et al. Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis. New Microbiol. 2005 Jul;28(3):199-203.</mixed-citation><mixed-citation xml:lang="en">Pietropaolo V, Fioriti D, Mischitelli M, et al. Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis. New Microbiol. 2005 Jul;28(3):199-203.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sotelo J, Ordonez G, Pineda B, Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg. 2014 Apr;119:44-8. Feb;30(1):101-7. doi: 10.1097/QCO.0000000000000332 им. С.С. Корсакова. Спецвыпуски. 2014;114(2-2):29-34. doi: 10.1016/j.clineuro.2013.12.020. Epub 2014 Jan 10.</mixed-citation><mixed-citation xml:lang="en">Sotelo J, Ordonez G, Pineda B, Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg. 2014 Apr;119:44-8. Feb;30(1):101-7. doi: 10.1097/QCO.0000000000000332 им. С.С. Корсакова. Спецвыпуски. 2014;114(2-2):29-34. doi: 10.1016/j.clineuro.2013.12.020. Epub 2014 Jan 10.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ramesh G, Didier PJ, England JD, et al. Inflammation in the pathogenesis of lyme neuroborreliosis. Am J Pathol. 2015 May;185(5):1344-60. doi: 10.1016/j.ajpath.2015.01.024. Epub 2015 Apr 16.</mixed-citation><mixed-citation xml:lang="en">Ramesh G, Didier PJ, England JD, et al. Inflammation in the pathogenesis of lyme neuroborreliosis. Am J Pathol. 2015 May;185(5):1344-60. doi: 10.1016/j.ajpath.2015.01.024. Epub 2015 Apr 16.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng X, Meng X, Chen R, et al. The molecular subtypes of autoimmune diseases. Comput Struct Biotechnol J. 2024 Mar 28;23:1348-63. doi: 10.1016/j.csbj.2024.03.026</mixed-citation><mixed-citation xml:lang="en">Cheng X, Meng X, Chen R, et al. The molecular subtypes of autoimmune diseases. Comput Struct Biotechnol J. 2024 Mar 28;23:1348-63. doi: 10.1016/j.csbj.2024.03.026</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lee YE, Lee SH, Kim WU. Cytokines, Vascular Endothelial Growth Factors, and PlGF in Autoimmunity: Insights From Rheumatoid Arthritis to Multiple Sclerosis. Immune Netw. 2024 Feb 16;24(1):e10. doi: 10.4110/in.2024.24.e10</mixed-citation><mixed-citation xml:lang="en">Lee YE, Lee SH, Kim WU. Cytokines, Vascular Endothelial Growth Factors, and PlGF in Autoimmunity: Insights From Rheumatoid Arthritis to Multiple Sclerosis. Immune Netw. 2024 Feb 16;24(1):e10. doi: 10.4110/in.2024.24.e10</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ogrinc K, Hernandez SA, Korva M, et al. Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis. Emerg Infect Dis. 2022 Apr;28(4):766-76. doi: 10.3201/eid2804.211831</mixed-citation><mixed-citation xml:lang="en">Ogrinc K, Hernandez SA, Korva M, et al. Unique Clinical, Immune, and Genetic Signature in Patients with Borrelial Meningoradiculoneuritis. Emerg Infect Dis. 2022 Apr;28(4):766-76. doi: 10.3201/eid2804.211831</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Gynthersen RMM, Orbaek M, Mens H, et al. Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study. Ticks Tick A longitudinal cohort study. Ticks Tick Borne Dis. 2023 Jan;14(1):102057. doi: 10.1016/j.ttbdis.2022.102057. Epub 2022 Oct 21.</mixed-citation><mixed-citation xml:lang="en">Gynthersen RMM, Orbaek M, Mens H, et al. Exploration of the induced cytokine responses in European Lyme neuroborreliosis: A longitudinal cohort study. Ticks Tick A longitudinal cohort study. Ticks Tick Borne Dis. 2023 Jan;14(1):102057. doi: 10.1016/j.ttbdis.2022.102057. Epub 2022 Oct 21.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C, Chu D, Kalantar-Zadeh K, et al. Cytokines: From Clinical Significance to Quantification. Adv Sci (Weinh). 2021 Aug;8(15):e2004433. doi: 10.1002/advs.202004433. Epub 2021 Jun 10.</mixed-citation><mixed-citation xml:lang="en">Liu C, Chu D, Kalantar-Zadeh K, et al. Cytokines: From Clinical Significance to Quantification. Adv Sci (Weinh). 2021 Aug;8(15):e2004433. doi: 10.1002/advs.202004433. Epub 2021 Jun 10.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Badawi A. The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection. Infect Dis Ther. 2017 Mar;6(1):85-102. doi: 10.1007/s40121-016-0138-6. Epub 2016 Nov 29.</mixed-citation><mixed-citation xml:lang="en">Badawi A. The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection. Infect Dis Ther. 2017 Mar;6(1):85-102. doi: 10.1007/s40121-016-0138-6. Epub 2016 Nov 29.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Eckman EA, Pacheco-Quinto J, Herdt AR, Halperin JJ. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy. Clin Infect Dis. 2018 Jun 18;67(1):80-8. doi: 10.1093/cid/ciy019</mixed-citation><mixed-citation xml:lang="en">Eckman EA, Pacheco-Quinto J, Herdt AR, Halperin JJ. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy. Clin Infect Dis. 2018 Jun 18;67(1):80-8. doi: 10.1093/cid/ciy019</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Баранова НС, Грись МС, Баранов АА и др. Клиническое значение определения цитокинов у пациентов с рассеянным склерозом и взаимосвязь с герпетической инфекцией. Вестник РГМУ. 2023;(4):51-65. doi: 10.24075/brsmu.2023.032</mixed-citation><mixed-citation xml:lang="en">Baranova NS, Gris MS, Baranov AA, et al. Clinical significance of cytokine counting in patients with multiple sclerosis and its relationship with herpetic infection. Vestnik RGMU = Bulletin of RSMU. 2023;(4):51-65. doi: 10.24075/brsmu.2023.032 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cerar T, Ogrinc K, Lotric-Furlan S, et al. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis. Clin Vaccine Immunol. 2013 Oct;20(10):1578-84. doi: 10.1128/CVI.00353-13. Epub 2013 Aug 14.</mixed-citation><mixed-citation xml:lang="en">Cerar T, Ogrinc K, Lotric-Furlan S, et al. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis. Clin Vaccine Immunol. 2013 Oct;20(10):1578-84. doi: 10.1128/CVI.00353-13. Epub 2013 Aug 14.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez SA, Ogrinc K, Korva M, et al. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerg Infect Dis. 2023 Jun;29(6):1091-101. doi: 10.3201/eid2906.221685</mixed-citation><mixed-citation xml:lang="en">Hernandez SA, Ogrinc K, Korva M, et al. Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerg Infect Dis. 2023 Jun;29(6):1091-101. doi: 10.3201/eid2906.221685</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Christophi GP, Gruber RC, Panos M, et al. Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol. 2012 Mar;142(3):308-19. doi: 10.1016/j.clim.2011.11.007. Epub 2011 Dec 2.</mixed-citation><mixed-citation xml:lang="en">Christophi GP, Gruber RC, Panos M, et al. Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients. Clin Immunol. 2012 Mar;142(3):308-19. doi: 10.1016/j.clim.2011.11.007. Epub 2011 Dec 2.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">D’Ambrosio A, Pontecorvo S, Colasanti T, et al. Peripheral blood biomarkers in multiple sclerosis. Autoimmun Rev. 2015 Dec;14(12):1097-110. doi: 10.1016/j.autrev.2015.07.014. Epub 2015 Jul 28.</mixed-citation><mixed-citation xml:lang="en">D’Ambrosio A, Pontecorvo S, Colasanti T, et al. Peripheral blood biomarkers in multiple sclerosis. Autoimmun Rev. 2015 Dec;14(12):1097-110. doi: 10.1016/j.autrev.2015.07.014. Epub 2015 Jul 28.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Melamud MM, Ermakov EA, Boiko AS, et al. Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis. Int J Mol Sci. 2022 Nov 10;23(22):13829. doi: 10.3390/ijms232213829</mixed-citation><mixed-citation xml:lang="en">Melamud MM, Ermakov EA, Boiko AS, et al. Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis. Int J Mol Sci. 2022 Nov 10;23(22):13829. doi: 10.3390/ijms232213829</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Soloski MJ, Crowder LA, Lahey LJ, et al. Serum inflammatory mediators as markers of human Lyme disease activity. PLoS One. 2014 Apr 16;9(4):e93243. doi: 10.1371/journal.pone.0093243</mixed-citation><mixed-citation xml:lang="en">Soloski MJ, Crowder LA, Lahey LJ, et al. Serum inflammatory mediators as markers of human Lyme disease activity. PLoS One. 2014 Apr 16;9(4):e93243. doi: 10.1371/journal.pone.0093243</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Бондаренко АЛ, Карань ЛС, бораторных показателей, концентрации IL-17A, IL-23, IL-33, IL-35 и специфических антител у пациентов с эритемной формой иксодового клещевого боррелиоза. РМЖ. Медицинское обозрение. 2018;8(2):55-61.</mixed-citation><mixed-citation xml:lang="en">Bondarenko AL, Karan LS, Lubeznova ON, Sapozhnikova VV. Complex characterization of clinical and laboratory parameters, IL-17A, IL-23, IL-33, IL-35 concentrations and specific antibodies in patients with erythematous form of ixodes tick-borreliosis. RMJ. Medical Review. 2018;8(2):55-61 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Strle K, Stupica D, Drouin EE, et al. Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clin Infect Dis. 2014 Feb;58(3):372-80. doi: 10.1093/cid/cit735. Epub 2013 Nov 11.</mixed-citation><mixed-citation xml:lang="en">Strle K, Stupica D, Drouin EE, et al. Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clin Infect Dis. 2014 Feb;58(3):372-80. doi: 10.1093/cid/cit735. Epub 2013 Nov 11.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Bockenstedt LK, Wooten RM, Baumgarth N. Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes. Curr Issues Mol Biol. 2021;42:145-90. doi: 10.21775/cimb.042.145. Epub 2020 Dec 8.</mixed-citation><mixed-citation xml:lang="en">Bockenstedt LK, Wooten RM, Baumgarth N. Immune Response to Borrelia: Lessons from Lyme Disease Spirochetes. Curr Issues Mol Biol. 2021;42:145-90. doi: 10.21775/cimb.042.145. Epub 2020 Dec 8.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Rojas JM, Avia M, Martin V, Sevilla N. IL-10: A Multifunctional Cytokine in Viral Infections. J Immunol Res. 2017;2017:6104054. doi: 10.1155/2017/6104054. Epub 2017 Feb 20.</mixed-citation><mixed-citation xml:lang="en">Rojas JM, Avia M, Martin V, Sevilla N. IL-10: A Multifunctional Cytokine in Viral Infections. J Immunol Res. 2017;2017:6104054. doi: 10.1155/2017/6104054. Epub 2017 Feb 20.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Lazarus JJ, Kay MA, McCarter AL, Wooten RM. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun. 2008 Mar;76(3):1153-62. doi: 10.1128/IAI.01404-07. Epub 2007 Dec 17.</mixed-citation><mixed-citation xml:lang="en">Lazarus JJ, Kay MA, McCarter AL, Wooten RM. Viable Borrelia burgdorferi enhances interleukin-10 production and suppresses activation of murine macrophages. Infect Immun. 2008 Mar;76(3):1153-62. doi: 10.1128/IAI.01404-07. Epub 2007 Dec 17.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Chung Y, Zhang N, Wooten RM. Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and/or dendritic cells. PLoS One. 2013 Dec 19;8(12):e84980. doi: 10.1371/journal.pone.0084980. Erratum in: PLoS One. 2014;9(1). doi: 10.1371/annotation/2ce59bc4-fcf0-498f-86f0-376432428bf4. Erratum in: PLoS One. 2014;9(1). doi: 10.1371/annotation/680090aa-3e1b-4135-94d6-8082c09180d4</mixed-citation><mixed-citation xml:lang="en">Chung Y, Zhang N, Wooten RM. Borrelia burgdorferi elicited-IL-10 suppresses the production of inflammatory mediators, phagocytosis, and expression of co-stimulatory receptors by murine macrophages and/or dendritic cells. PLoS One. 2013 Dec 19;8(12):e84980. doi: 10.1371/journal.pone.0084980. Erratum in: PLoS One. 2014;9(1). doi: 10.1371/annotation/2ce59bc4-fcf0-498f-86f0-376432428bf4. Erratum in: PLoS One. 2014;9(1). doi: 10.1371/annotation/680090aa-3e1b-4135-94d6-8082c09180d4</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis VA, Jefferson A, Singh SR, et al. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3. Infect Immun. 2006 Oct;74(10):5780-9. doi: 10.1128/IAI.00678-06</mixed-citation><mixed-citation xml:lang="en">Dennis VA, Jefferson A, Singh SR, et al. Interleukin-10 anti-inflammatory response to Borrelia burgdorferi, the agent of Lyme disease: a possible role for suppressors of cytokine signaling 1 and 3. Infect Immun. 2006 Oct;74(10):5780-9. doi: 10.1128/IAI.00678-06</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Schönrich G, Abdelaziz MO, Raftery MJ. Epstein-Barr virus, interleukin-10 and multiple sclerosis: A menage a trois. Front Immunol. 2022 Oct 7;13:1028972. doi: 10.3389/fimmu.2022.1028972</mixed-citation><mixed-citation xml:lang="en">Schönrich G, Abdelaziz MO, Raftery MJ. Epstein-Barr virus, interleukin-10 and multiple sclerosis: A menage a trois. Front Immunol. 2022 Oct 7;13:1028972. doi: 10.3389/fimmu.2022.1028972</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Watford WT, Moriguchi M, Morinobu A, O’Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003 Oct;14(5):361-8. doi: 10.1016/s1359-6101(03)00043-1</mixed-citation><mixed-citation xml:lang="en">Watford WT, Moriguchi M, Morinobu A, O’Shea JJ. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003 Oct;14(5):361-8. doi: 10.1016/s1359-6101(03)00043-1</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Broberg EK, Setälä N, Erälinna JP, et al. Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice. J Interferon Cytokine Res. 2002 Jun;22(6):641-51. doi: 10.1089/10799900260100123</mixed-citation><mixed-citation xml:lang="en">Broberg EK, Setälä N, Erälinna JP, et al. Herpes simplex virus type 1 infection induces upregulation of interleukin-23 (p19) mRNA expression in trigeminal ganglia of BALB/c mice. J Interferon Cytokine Res. 2002 Jun;22(6):641-51. doi: 10.1089/10799900260100123</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Cayrol C, Girard JP. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. Immunol Rev. 2018 Jan;281(1):154-68. doi: 10.1111/imr.12619</mixed-citation><mixed-citation xml:lang="en">Cayrol C, Girard JP. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family. Immunol Rev. 2018 Jan;281(1):154-68. doi: 10.1111/imr.12619</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021 May;18(5):1106-21. doi: 10.1038/s41423-020-00630-3. Epub 2021 Mar 30.</mixed-citation><mixed-citation xml:lang="en">Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021 May;18(5):1106-21. doi: 10.1038/s41423-020-00630-3. Epub 2021 Mar 30.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Verzosa AL, McGeever LA, Bhark SJ, et al. Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms. Front Immunol. 2021 May 31;12:644664. doi: 10.3389/fimmu.2021.644664</mixed-citation><mixed-citation xml:lang="en">Verzosa AL, McGeever LA, Bhark SJ, et al. Herpes Simplex Virus 1 Infection of Neuronal and Non-Neuronal Cells Elicits Specific Innate Immune Responses and Immune Evasion Mechanisms. Front Immunol. 2021 May 31;12:644664. doi: 10.3389/fimmu.2021.644664</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun. 2006 Sep;7(6):522-31. doi: 10.1038/sj.gene.6364324. Epub 2006 Jul 13.</mixed-citation><mixed-citation xml:lang="en">Van Baarsen LG, van der Pouw Kraan TC, Kragt JJ, et al. A subtype of multiple sclerosis defined by an activated immune defense program. Genes Immun. 2006 Sep;7(6):522-31. doi: 10.1038/sj.gene.6364324. Epub 2006 Jul 13.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Van de Schoor FR, Vrijmoeth HD, Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12. Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7.</mixed-citation><mixed-citation xml:lang="en">Van de Schoor FR, Vrijmoeth HD, Is a Poor Inducer of Gamma Interferon: Amplification Induced by Interleukin-12. Infect Immun. 2022 Mar 17;90(3):e0055821. doi: 10.1128/iai.00558-21. Epub 2022 Feb 7.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Vrijmoeth HD, Ursinus J, Botey-Bataller J, et al. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications. BMC Infect Dis. 2024 Mar 21;24(1):337. doi: 10.1186/s12879-024-09217-z</mixed-citation><mixed-citation xml:lang="en">Vrijmoeth HD, Ursinus J, Botey-Bataller J, et al. Genome-wide analyses in Lyme borreliosis: identification of a genetic variant associated with disease susceptibility and its immunological implications. BMC Infect Dis. 2024 Mar 21;24(1):337. doi: 10.1186/s12879-024-09217-z</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
